Stock Market

Microsoft’s (NASDAQ:MSFT) potential investment in an artificial intelligence (AI) chatbot is a hot topic on Wall Street now. Yet, MSFT stock traders should consider the implications carefully before pressing the “buy” button. There’s also earnings season coming up, and it’s not a sure bet that Microsoft will hit a home run this time. During the days
0 Comments
Stocks of electric vehicle (EV) makers were battered in 2022. Chip shortages, supply chain bottlenecks, Covid-19-led disruptions in China and macro headwinds took a toll on the industry. Yet, the long-term prospects for EV companies remain attractive due to growing consumer interest, favorable regulation and tax credits to boost EV adoption. Strategic research provider BloombergNEF
0 Comments
Invariably, with the Federal Reserve forced into the unenviable task of taking away the monetary punch bowl, certain stocks to avoid would come up based on mass layoffs. Effectively, the earlier response to the coronavirus pandemic led to a dramatic rise in the real M2 money stock. However, inflation didn’t become particularly pronounced until people
0 Comments
Are you ready to spin the wheel and take a chance on Bally’s (NYSE:BALY)? Not so fast, as BALY stock could continue to lose value in 2023. A turnaround in macroeconomic conditions would certainly help Bally’s recover from its slump. Yet, the company’s fiscal figures should set off some alarm bells for cautious investors. Don’t get
0 Comments
Tilray (NASDAQ:TLRY) stock could rise or fall in 2023, based on whether American legislators make progress with pro-cannabis bills. While TLRY is a Canadian company, it sells cannabis-related products throughout North America. Thus, U.S. marijuana laws are highly relevant to Tilray and its stakeholders.  So far, this looks like a steep uphill battle, and that’s bad news
0 Comments
Folks who held shares of Rivian Automotive (NASDAQ:RIVN) stock had a rough ride last year. Will 2023 be any better? The outlook is dim, and perhaps a bit grim, as Rivian’s cash position isn’t ideal. Plus, supply chain disruptions could continue to cause problems for the automaker. Frankly, you probably won’t want to load up
0 Comments
There are several reasons why it’s best to steer clear of Alphabet (NASDAQ:GOOG,NASDAQ:GOOGL) shares. Among these various reasons, a key one that could affect the future performance of GOOG stock is rising competition. High competition is having a greater impact on Alphabet’s cloud computing and streaming segments. However, not even its bread-and-butter search advertising segment
0 Comments
While it’s always risky to go against the masses, certain short-squeeze stocks for contrarians to consider may perform surprisingly well. Invariably, even the collective sometimes gets things wrong. Certainly, if everyone bets on the same horse, the subsequent individual reward (if any) would be significantly limited. And that’s part of the reason why going against
0 Comments
In 2022, I was able to greatly reduce my stock portfolio’s losses by shorting several U.S. equities. I found it fairly easy to find favorable stocks to short, as the valuations of many companies were ridiculously high last year, and many stocks were pricing in scenarios that almost certainly would never materialize. For example, I
0 Comments
Shares in SoFi Technologies (NASDAQ:SOFI) have traded sideways over the past month. This is not surprising, given there have not been too many headlines about SOFI stock, since the short-lived excitement surrounding news of insider buying by CEO Anthony Noto. That said, there is something on the horizon that will likely bring this fintech stock
0 Comments
For investors in a wide swath of companies, 2022 was a rough year. That said, it was a downright brutal year for those invested in most tech companies. Indeed, the three stocks on this list are among the mega-cap juggernauts of the tech world. With market capitalizations ranging from $335 billion to more than $2
0 Comments
After a bruising 2022, how will electric vehicle (EV) manufacturer Lucid Group (NASDAQ:LCID) treat its loyal investors during the next 12 months? It’s hard to envision a strong bull case for LCID stock as there no clear positive catalysts. Lucid did raise capital recently, but it wasn’t “free money” by any means. Moreover, the automaker’s
0 Comments
Biotech stocks are in high demand right now, with good reason. Indeed, these biotech companies have the potential to revolutionize the medical world and offer solutions to unmet needs, while their relevance is recession-proof. With growing demand for gene therapies, immune oncology, and precision medicine, biotech companies have a unique opportunity to impact the world
0 Comments